Skip to main content
Toggle navigation
Login
Search
Home
Tweets by ASCPT 2023 Annual Meeting
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
N
Nayak, Satyaprakash
Pfizer
PII-104
-
INDIVIDUAL DOSE OPTIMIZATION FOR SOMATROGON BY MODELING AND SHINY INTERFACE.
Satyaprakash Nayak
Favorite
Neal, Reem
Mayo Clinic
PT-026
-
TRANSCRIPTOMIC PROFILING OF PTRPD KNOCK-DOWN IN HUMAN IPSC-DERIVED NEURONS REVEALED A ROLE IN ALCOHOL USE DISORDER DRUG TREATMENT RESPONSE.
Reem Neal
Favorite
Nepal, Mahesh
The Ohio State University
PII-028
-
PACIFIC BLUE DERIVATIVES OF PACLITAXEL AS FLUORESCENT PROBES OF ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B (OATP1B) TRANSPORTERS.
Mahesh Nepal
Favorite
Nguyen, Duyen
US Food and Drug Administration
PI-084
-
EXPLORATION FOR EXCLUSION OF FEMALES OF REPRODUCTIVE POTENTIAL AS A BIOEQUIVALENCE STUDY POPULATION IN PRODUCT-SPECIFIC GUIDANCES FOR GENERIC DRUG DEVELOPMENT.
Duyen Nguyen
Favorite
PWIV-001
-
EXPLORATION FOR EXCLUSION OF FEMALES OF REPRODUCTIVE POTENTIAL AS A BIOEQUIVALENCE STUDY POPULATION IN PRODUCT-SPECIFIC GUIDANCES FOR GENERIC DRUG DEVELOPMENT.
Duyen Nguyen
Favorite
Nguyen, James
Washington State University
PI-040
-
ASSESSING THE GOLDENSEAL-METFORMIN PHARMACOKINETIC INTERACTION IN TYPE 2 DIABETICS.
James Nguyen
Favorite
Nguyen, Thomas
University at Buffalo
PT-004
-
PROSPECTIVE VALIDATION OF MAXIMUM A POSTERIORI-BAYESIAN ESTIMATION OF TACROLIMUS EXPOSURE IN STABLE KIDNEY TRANSPLANT RECIPIENTS.
Thomas Nguyen
Favorite
Noormohamed, Nadia
GlaxoSmithKline
PI-006
-
PHARMACOKINETICS AND SAFETY OF SINGLE-DOSE BEPIROVERSIN IN ADULTS WITH MODERATE HEPATIC IMPAIRMENT AND HEALTHY MATCHED CONTROLS (B-ASSURED).
Nadia Noormohamed
Favorite
PII-023
-
RISK OF QT PROLONGATION WITH OLIGONUCLEOTIDES: A REVIEW OF PUBLISHED EVIDENCE.
Nadia Noormohamed
Favorite
Novakovic, Jasmina
Simulations Plus Inc
LB-013
-
PHYSIOLOGICALLY BASED ABSORPTION AND PHARMACOKINETIC MODEL FOR RIVOCERANIB AND ITS MAIN METABOLITE TO ASSESS POTENTIAL CYP3A4-MEDIATED DDI RISK.
Jasmina Novakovic
Favorite